The Global Initiative on Sharing All Influenza Data (GISAID) is one of the databases compiling all of the geno
The Global Initiative on Sharing All Influenza Data (GISAID) is one of the databases compiling all of the genome sequencing of COVID-19. The disease is being repeatedly sequenced to track it mutations.
Genome sequencing of the disease is being done all of over the world and we are nearly at 8000 genome sequences.
Genome sequences are being pooled into several databases that are vital for tracking how the virus mutates over time as it spreads and for the development of diagnostic tests and vaccines.
Europe has performed 52% of the COVID-19 genome sequences.North America has 23%.Asia has 15%.
Africa and South America have each performed 1%.
The lack of sequencing could mean that any vaccines or treatment might not work as well for Africa and South American strains of COVID-19.
Brian Wang is a prolific business-oriented writer of emerging and disruptive technologies. He is known for insightful articles that combine business and technical analysis that catches the attention of the general public and is also useful for those in the industries. He is the sole author and writer of nextbigfuture.com, the top online science blog. He is also involved in angel investing and raising funds for breakthrough technology startup companies.
He gave the recent keynote presentation at Monte Jade event with a talk entitled the Future for You. He gave an annual update on molecular nanotechnology at Singularity University on nanotechnology, gave a TEDX talk on energy, and advises USC ASTE 527 (advanced space projects program). He has been interviewed for radio, professional organizations. podcasts and corporate events. He was recently interviewed by the radio program Steel on Steel on satellites and high altitude balloons that will track all movement in many parts of the USA.
He fundraises for various high impact technology companies and has worked in computer technology, insurance, healthcare and with corporate finance.
He has substantial familiarity with a broad range of breakthrough technologies like age reversal and antiaging, quantum computers, artificial intelligence, ocean tech, agtech, nuclear fission, advanced nuclear fission, space propulsion, satellites, imaging, molecular nanotechnology, biotechnology, medicine, blockchain, crypto and many other areas.